Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
biOasis Technologies Ord Shs
BIOAF
Primary Symbol:
V.BTI.H
Healthcare
Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in...
particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:BTI.H)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(107)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Mar 01, 2023 8:27am
22 days since...
22 days since narmac posted: "Hummmm,,well,,,,where did this informatuion come from,,,,,,,you say Bioasis is dead??,,no,,you arent rerading the info,,,the deal is dead,,,,not Bioasis,,,,,,good
...more
(107)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Feb 28, 2023 4:35pm
RE:#RareDiseaseDay
Cash until March and we are here... 19 days ago Midatech announced its financing with Ladenberg. BTI was recognized as far more valuable in the Biodexa transaction. If all that was next for BTI was
...more
NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets
posted Nov 14, 2024 9:00am by
NurExone Biologic Inc.
-
|
“We are honored by the EMA’s recognition of ExoPTEN through the Orphan Medicinal Product Designation, which significantly advances our ability to enter the European market and offers hope to those impacted by acute spinal cord injuries,” said Dr. Lior Shaltiel, Chief Executive Officer of NurExone. “This designation, together with the ...read more
(40)
•••
zwerp2000
X
View Profile
View Bullboard History
Comment by
zwerp2000
on Feb 28, 2023 1:25pm
RE:RE:Poof and Boom are too funny
Poof has ulterior motives. Not sure what is going on with him but he's not someone to trust
(2261)
•••
Boomskid
X
View Profile
View Bullboard History
Comment by
Boomskid
on Feb 28, 2023 1:15pm
RE:Poof and Boom are too funny
zwerp2000, poof's answer to your post was to repost one of his previous posts so that your post was no longer the top post. That's what poof's posts are mostly about, being the topmost
...more
(107)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Feb 28, 2023 12:24pm
#RareDiseaseDay
@BioasisUS
...more
(40)
•••
zwerp2000
X
View Profile
View Bullboard History
Post by
zwerp2000
on Feb 28, 2023 12:19pm
Poof and Boom are too funny
You spend so much of your time going back and forth about a company that trades at $.01, has no money, has a failed platform (yes, this platform is a failure), that tried to sell itself to another
...more
(2261)
•••
Boomskid
X
View Profile
View Bullboard History
Comment by
Boomskid
on Feb 28, 2023 9:45am
RE:RE:RE:RE:RE:$5.25 million
Yes, poof, I agree. Sell the EGF stuff. Bioasis might get enough to make a couple of payments on the Lind convertible debt. Remember that the EGF things that are "clinic ready" are not xB3
...more
(107)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Feb 28, 2023 9:28am
RE:RE:RE:RE:$5.25 million
BTI could sell the upfront EGF opportunities for upfront cash and keep the xB3 applications. BTI is potentially opportunity rich at $.02 and this may provide a surprise escape.
(2261)
•••
Boomskid
X
View Profile
View Bullboard History
Comment by
Boomskid
on Feb 28, 2023 9:27am
RE:RE:RE:$5.25 million
Royalties? From Chiesi? They haven't even produced a developmental or regulatory milestone payment yet, let alone a commercial milestone or royalty payment. C$1.5 billion in royalties? Of
...more
(2261)
•••
Boomskid
X
View Profile
View Bullboard History
Comment by
Boomskid
on Feb 28, 2023 9:20am
RE:RE:RE:$5.25 million
Yes, poof, Chiesi Global Rare Diseases is in the rare disease business. There are so many companies that claim to be in the rare disease space that the term has lost most of its meaning. And, yes
...more
(107)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Feb 28, 2023 9:09am
RE:RE:$5.25 million
"$3 million up front and only $138 million in milestone payments for 4 LSDs." You don't mention the potential royalties on C$1.5 billion at peak sales, or whatever.
(107)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Feb 28, 2023 9:08am
RE:RE:$5.25 million
Chiesi is into rare diseases. It could sell the LSD franchine and also enter a deal on EGF.
(2261)
•••
Boomskid
X
View Profile
View Bullboard History
Comment by
Boomskid
on Feb 28, 2023 9:01am
RE:$5.25 million
Hah, poof, thank you for recognizing the LSD deal I have proposed for years. I proposed selling the entire rights to LSDs for $30 million to $50 million, all in, no royalties, possibly enough to get
...more
(107)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Feb 28, 2023 8:04am
$5.25 million
BTI received $5.25 million upfront for 4 LSDs. If there is a way out of BTI's predicament that doesn't issue shares what could it look like? If BTI sold 4 LSDs to Chiesi and XOMA for $5.25
...more
(2261)
•••
Boomskid
X
View Profile
View Bullboard History
Comment by
Boomskid
on Feb 27, 2023 9:01pm
RE:$.02
I forgot. Bioasis is not at 1.5¢ today. Bioasis was up 33.3% today, from 1.5¢ to 2¢. Does Bioasis still have a deal with Prothena? My guess? Yes, but I doubt any work is being done. It
...more
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Coppernico Drills 19 Meters of 0.50% Copper in First 5 Holes and Applies for Additional Permits
Explained: The Psychology of Options Trading with Practical Tips
Meet the Top 5 Best Online Brokerages in Canada
New Gold and Copper Hotspot Identified – What’s Next for This Serbian Project?
Major Funding Secured! Company Closes First Round of Private Placement
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.
Geodrill Generates Revenue of $34.1M, a 13% Increase Compared to $30.3M for Q3-2023
Gold, growth and sustainability in focus for this resource company
Star Diamond Corporation Announces Third Quarter 2024 Results
This $10M Deal Could Reshape the Future of Global Creator Platforms